ACRV
Acrivon Therapeutics, Inc.
1.90$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Acrivon Therapeutics, Inc. (ACRV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -64 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -2.8 | -14 | -30 | -43 | -66 | -64 | |
| 0.0 | 0.0 | 0.4 | 0.5 | 1.0 | 0.9 | |
| 0.0 | 0.5 | 2.2 | 12 | 14 | 15 | |
| 2.2 | 1.9 | 2.2 | – | – | – | |
| 0.3 | 0.3 | -1.5 | 8.1 | 2.4 | -2.4 | |
| 0.0 | 0.2 | 2.2 | 1.3 | 2.8 | 1.7 | |
| 0.0 | -0.2 | -142 | 51 | -52 | 66 | |
| – | – | 102 | – | – | – | |
| 0.1 | 0.0 | – | – | – | – | |
| 2.9 | 112 | 102 | -1.6 | 121 | -0.7 | |
| 0.1 | 98 | -70 | 6.5 | 3.6 | 1.7 | |
| -2.8 | -14 | -32 | -44 | -68 | -65 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.